{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:40Z","timestamp":1789011580140,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001543","name":"Children's Cancer Foundation","doi-asserted-by":"publisher","award":["PROJ10\/052"],"award-info":[{"award-number":["PROJ10\/052"]}],"id":[{"id":"10.13039\/100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["K2012-64X-22020-01-3"],"award-info":[{"award-number":["K2012-64X-22020-01-3"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.bbmt.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T06:15:48Z","timestamp":1402121748000},"page":"1646-1649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Varicella-Zoster Reactivation after Allogeneic Stem Cell Transplantation without Routine Prophylaxis\u2014The Incidence Remains High"],"prefix":"10.1016","volume":"20","author":[{"given":"Ola","family":"Blennow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Fjaertoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Winiarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.06.002_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/10245330310001612125","article-title":"Immune reconstitution and early infectious complications following nonmyeloablative hematopoietic stem cell transplantation","volume":"8","author":"Busca","year":"2003","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2014.06.002_bib2","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications","volume":"13","author":"Han","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-3062.2007.00247.x","article-title":"Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders","volume":"10","author":"Kim","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2014.06.002_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbmt.2010.10.025","article-title":"High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation","volume":"17","author":"Su","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","article-title":"Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group","volume":"15","author":"Onozawa","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1705255","article-title":"Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen","volume":"37","author":"Frere","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.002_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.002_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.tp.0000233865.20232.51","article-title":"Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning","volume":"82","author":"Uzunel","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2014.06.002_bib12","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A\u00a0randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipient with leukemia","volume":"83","author":"Ringd\u00e9n","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.002_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","article-title":"Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation","volume":"24","author":"Remberger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.002_bib14","first-page":"137","article-title":"Acyclovir prophylaxis in bone marrow transplant recipients","volume":"47","author":"Lundgren","year":"1985","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.bbmt.2014.06.002_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1399-3062.2003.00027.x","article-title":"Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"5","author":"Busca","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2014.06.002_bib16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","article-title":"Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation","volume":"99","author":"Reusser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.002_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"Proportional hazard model for the sub-distribution of competing risks","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2014.06.002_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0609.2012.01824.x","article-title":"Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation","volume":"89","author":"Forslow","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2014.06.002_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12185-012-1218-3","article-title":"Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients","volume":"96","author":"Remberger","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2014.06.002_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/13550284.2010.513031","article-title":"Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation","volume":"16","author":"Mahalingam","year":"2010","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.bbmt.2014.06.002_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/tid.12180","article-title":"Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity","volume":"16","author":"Vermont","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2014.06.002_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2003.11.002","article-title":"Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia","volume":"10","author":"Nordlander","year":"2004","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114003498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114003498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:53Z","timestamp":1761058193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114003498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1083879114003498"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.06.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella-Zoster Reactivation after Allogeneic Stem Cell Transplantation without Routine Prophylaxis\u2014The Incidence Remains High","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}